Logo image of JCI

JOHNSON CONTROLS INTERNATION (JCI) Stock Fundamental Analysis

NYSE:JCI - New York Stock Exchange, Inc. - IE00BY7QL619 - Common Stock - Currency: USD

85.28  -3.55 (-4%)

After market: 85.14 -0.14 (-0.16%)

Fundamental Rating

4

JCI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 40 industry peers in the Building Products industry. While JCI is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, JCI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

JCI had positive earnings in the past year.
JCI had a positive operating cash flow in the past year.
JCI had positive earnings in each of the past 5 years.
JCI had a positive operating cash flow in each of the past 5 years.
JCI Yearly Net Income VS EBIT VS OCF VS FCFJCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

The Return On Assets of JCI (4.16%) is worse than 70.00% of its industry peers.
JCI's Return On Equity of 11.01% is in line compared to the rest of the industry. JCI outperforms 42.50% of its industry peers.
JCI has a Return On Invested Capital of 6.10%. This is in the lower half of the industry: JCI underperforms 70.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JCI is significantly below the industry average of 13.20%.
Industry RankSector Rank
ROA 4.16%
ROE 11.01%
ROIC 6.1%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
JCI Yearly ROA, ROE, ROICJCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

With a Profit Margin value of 7.85%, JCI perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
JCI's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.06%, JCI is in line with its industry, outperforming 45.00% of the companies in the same industry.
In the last couple of years the Operating Margin of JCI has grown nicely.
JCI has a Gross Margin (35.95%) which is in line with its industry peers.
In the last couple of years the Gross Margin of JCI has grown nicely.
Industry RankSector Rank
OM 11.06%
PM (TTM) 7.85%
GM 35.95%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
JCI Yearly Profit, Operating, Gross MarginsJCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

JCI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, JCI has less shares outstanding
JCI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for JCI is higher compared to a year ago.
JCI Yearly Shares OutstandingJCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
JCI Yearly Total Debt VS Total AssetsJCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

JCI has an Altman-Z score of 2.09. This is not the best score and indicates that JCI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.09, JCI is doing worse than 75.00% of the companies in the same industry.
The Debt to FCF ratio of JCI is 4.83, which is a neutral value as it means it would take JCI, 4.83 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.83, JCI is doing worse than 62.50% of the companies in the same industry.
A Debt/Equity ratio of 0.60 indicates that JCI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.60, JCI is in line with its industry, outperforming 47.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 4.83
Altman-Z 2.09
ROIC/WACC0.91
WACC6.69%
JCI Yearly LT Debt VS Equity VS FCFJCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

JCI has a Current Ratio of 1.02. This is a normal value and indicates that JCI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.02, JCI is not doing good in the industry: 92.50% of the companies in the same industry are doing better.
JCI has a Quick Ratio of 1.02. This is a bad value and indicates that JCI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.86, JCI is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.86
JCI Yearly Current Assets VS Current LiabilitesJCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.97% over the past year.
Measured over the past years, JCI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.04% on average per year.
The Revenue for JCI has decreased by -16.91% in the past year. This is quite bad
Measured over the past years, JCI shows a decrease in Revenue. The Revenue has been decreasing by -0.86% on average per year.
EPS 1Y (TTM)14.97%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%25.49%
Revenue 1Y (TTM)-16.91%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-10.96%

3.2 Future

The Earnings Per Share is expected to grow by 9.68% on average over the next years. This is quite good.
Based on estimates for the next years, JCI will show a small growth in Revenue. The Revenue will grow by 3.16% on average per year.
EPS Next Y-1.4%
EPS Next 2Y7.23%
EPS Next 3Y9.91%
EPS Next 5Y9.68%
Revenue Next Year-12.13%
Revenue Next 2Y-4.01%
Revenue Next 3Y-0.96%
Revenue Next 5Y3.16%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JCI Yearly Revenue VS EstimatesJCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
JCI Yearly EPS VS EstimatesJCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.21 indicates a rather expensive valuation of JCI.
JCI's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 29.63. JCI is valued slightly cheaper when compared to this.
JCI is valuated rather expensively with a Price/Forward Earnings ratio of 19.99.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JCI is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of JCI to the average of the S&P500 Index (22.68), we can say JCI is valued inline with the index average.
Industry RankSector Rank
PE 22.21
Fwd PE 19.99
JCI Price Earnings VS Forward Price EarningsJCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

JCI's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. JCI is more expensive than 72.50% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JCI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 27.18
EV/EBITDA 20.52
JCI Per share dataJCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.7
EPS Next 2Y7.23%
EPS Next 3Y9.91%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.67%, JCI has a reasonable but not impressive dividend return.
JCI's Dividend Yield is rather good when compared to the industry average which is at 1.10. JCI pays more dividend than 95.00% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.29, JCI is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

On average, the dividend of JCI grows each year by 6.63%, which is quite nice.
JCI has been paying a dividend for at least 10 years, so it has a reliable track record.
As JCI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)6.63%
Div Incr Years3
Div Non Decr Years6
JCI Yearly Dividends per shareJCI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

JCI pays out 56.74% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of JCI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.74%
EPS Next 2Y7.23%
EPS Next 3Y9.91%
JCI Yearly Income VS Free CF VS DividendJCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B
JCI Dividend Payout.JCI Dividend Payout, showing the Payout Ratio.JCI Dividend Payout.PayoutRetained Earnings

JOHNSON CONTROLS INTERNATION

NYSE:JCI (2/21/2025, 8:04:00 PM)

After market: 85.14 -0.14 (-0.16%)

85.28

-3.55 (-4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)02-05 2025-02-05/bmo
Earnings (Next)N/A N/A
Inst Owners94.25%
Inst Owner Change-0.79%
Ins Owners0.34%
Ins Owner Change-0.75%
Market Cap56.30B
Analysts75.56
Price Target90.51 (6.13%)
Short Float %1.44%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend1.49
Dividend Growth(5Y)6.63%
DP56.74%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.61%
Min EPS beat(2)5.59%
Max EPS beat(2)7.63%
EPS beat(4)4
Avg EPS beat(4)4.96%
Min EPS beat(4)2.37%
Max EPS beat(4)7.63%
EPS beat(8)5
Avg EPS beat(8)1.82%
EPS beat(12)5
Avg EPS beat(12)0.95%
EPS beat(16)7
Avg EPS beat(16)0.99%
Revenue beat(2)2
Avg Revenue beat(2)1.82%
Min Revenue beat(2)1.59%
Max Revenue beat(2)2.04%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)2.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.3%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)0.25%
PT rev (3m)9.95%
EPS NQ rev (1m)3.46%
EPS NQ rev (3m)-12.37%
EPS NY rev (1m)1.97%
EPS NY rev (3m)-1.52%
Revenue NQ rev (1m)-2.72%
Revenue NQ rev (3m)-20.17%
Revenue NY rev (1m)-1.58%
Revenue NY rev (3m)-5.1%
Valuation
Industry RankSector Rank
PE 22.21
Fwd PE 19.99
P/S 2.53
P/FCF 27.18
P/OCF 21.74
P/B 3.54
P/tB N/A
EV/EBITDA 20.52
EPS(TTM)3.84
EY4.5%
EPS(NY)4.27
Fwd EY5%
FCF(TTM)3.14
FCFY3.68%
OCF(TTM)3.92
OCFY4.6%
SpS33.76
BVpS24.09
TBVpS-6.78
PEG (NY)N/A
PEG (5Y)1.7
Profitability
Industry RankSector Rank
ROA 4.16%
ROE 11.01%
ROCE 7.94%
ROIC 6.1%
ROICexc 6.35%
ROICexgc 18.93%
OM 11.06%
PM (TTM) 7.85%
GM 35.95%
FCFM 9.29%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
ROICexc(3y)6.58%
ROICexc(5y)6.25%
ROICexgc(3y)23.86%
ROICexgc(5y)23.9%
ROCE(3y)8.19%
ROCE(5y)7.69%
ROICexcg growth 3Y-13.87%
ROICexcg growth 5Y1.5%
ROICexc growth 3Y-4.43%
ROICexc growth 5Y10.29%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 4.83
Debt/EBITDA 2.92
Cap/Depr 66.58%
Cap/Sales 2.32%
Interest Coverage 250
Cash Conversion 79.86%
Profit Quality 118.34%
Current Ratio 1.02
Quick Ratio 0.86
Altman-Z 2.09
F-Score6
WACC6.69%
ROIC/WACC0.91
Cap/Depr(3y)65.14%
Cap/Depr(5y)62.93%
Cap/Sales(3y)2.17%
Cap/Sales(5y)2.16%
Profit Quality(3y)91.89%
Profit Quality(5y)135.07%
High Growth Momentum
Growth
EPS 1Y (TTM)14.97%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%25.49%
EPS Next Y-1.4%
EPS Next 2Y7.23%
EPS Next 3Y9.91%
EPS Next 5Y9.68%
Revenue 1Y (TTM)-16.91%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-10.96%
Revenue Next Year-12.13%
Revenue Next 2Y-4.01%
Revenue Next 3Y-0.96%
Revenue Next 5Y3.16%
EBIT growth 1Y-10.37%
EBIT growth 3Y-4.81%
EBIT growth 5Y10.77%
EBIT Next Year10.96%
EBIT Next 3Y10.67%
EBIT Next 5Y8.77%
FCF growth 1Y191.28%
FCF growth 3Y-6.18%
FCF growth 5Y20.42%
OCF growth 1Y98.85%
OCF growth 3Y-5.6%
OCF growth 5Y11.44%